Literature DB >> 31757301

Heated Intravesical Chemotherapy: Biology and Clinical Utility.

Wei Phin Tan1, Thomas A Longo1, Brant A Inman2.   

Abstract

Non-muscle-invasive bladder cancer can be a challenging disease to manage. In recent years, hyperthermia therapy in conjunction with intravesical therapy has been gaining traction as a treatment option for bladder cancer, especially if Bacillus Calmette-Guerin might not be available. Trials of intravesical chemotherapy with heat are few and there has been considerable heterogeneity between studies. However, multiple new trials have accrued and high-quality data are forthcoming. In this review, we discuss the role of combined intravesical hyperthermia and chemotherapy as a novel approach for the treatment of bladder cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder hyperthermia; HIVEC; Heated chemotherapy; Heated mitomycin; Intravesical chemotherapy; Intravesical mitomycin

Mesh:

Substances:

Year:  2020        PMID: 31757301      PMCID: PMC6917042          DOI: 10.1016/j.ucl.2019.09.008

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  64 in total

1.  10-year single-center experience of combined intravesical chemohyperthermia for nonmuscle invasive bladder cancer.

Authors:  Boaz Moskovitz; Sarel Halachmi; Michal Moskovitz; Omri Nativ; Ofer Nativ
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

2.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors:  J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

Review 3.  Old and new facts about hyperthermia-induced modulations of the immune system.

Authors:  Benjamin Frey; Eva-Maria Weiss; Yvonne Rubner; Roland Wunderlich; Oliver J Ott; Rolf Sauer; Rainer Fietkau; Udo S Gaipl
Journal:  Int J Hyperthermia       Date:  2012-06-12       Impact factor: 3.914

4.  Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.

Authors:  Wei Shen Tan; Anesh Panchal; Laura Buckley; Adam J Devall; Laurence S Loubière; Ann M Pope; Mark R Feneley; Jo Cresswell; Rami Issa; Hugh Mostafid; Sanjeev Madaan; Rupesh Bhatt; John McGrath; Vijay Sangar; T R Leyshon Griffiths; Toby Page; Dominic Hodgson; Shibendra N Datta; Lucinda J Billingham; John D Kelly
Journal:  Eur Urol       Date:  2018-09-28       Impact factor: 20.096

5.  Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia.

Authors:  Michael Wittlinger; Claus M Rödel; Christian Weiss; Steffen F Krause; Reinhard Kühn; Rainer Fietkau; Rolf Sauer; Oliver J Ott
Journal:  Radiother Oncol       Date:  2009-11       Impact factor: 6.280

Review 6.  Hyperthermia in combined treatment of cancer.

Authors:  P Wust; B Hildebrandt; G Sreenivasa; B Rau; J Gellermann; H Riess; R Felix; P M Schlag
Journal:  Lancet Oncol       Date:  2002-08       Impact factor: 41.316

7.  Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer.

Authors:  R C Rietbroek; P J Bakker; M S Schilthuis; A J Postma; P J Zum Vörde Sive Vording; D Gonzalèz Gonzalèz; K H Kurth; A J Bakker; C H Veenhof
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-03-01       Impact factor: 7.038

Review 8.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

9.  Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.

Authors:  Christine Gan; Suzanne Amery; Kathryn Chatterton; Muhammad Shamim Khan; Kay Thomas; Tim O'Brien
Journal:  J Urol       Date:  2016-02-02       Impact factor: 7.450

10.  Robotic transmural ablation of bladder tumors using high-intensity focused ultrasound: Experimental study.

Authors:  Andre Luis de Castro Abreu; Osamu Ukimura; Sunao Shoji; Scott Leslie; Sameer Chopra; Arnaud Marien; Toru Matsugasumi; Arjuna Dharmaraja; Kelvin Wong; Natalie Zaba; Yanling Ma; Mihir M Desai; Inderbir S Gill
Journal:  Int J Urol       Date:  2016-04-01       Impact factor: 3.369

View more
  2 in total

1.  Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study.

Authors:  Wei Phin Tan; Andrew Chang; Steven C Brousell; Dominic C Grimberg; Joseph J Fantony; Thomas A Longo; Wiguins Etienne; Ivan Spasojevic; Paolo Maccarini; Brant A Inman
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

Review 2.  Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.

Authors:  Niloy R Datta; H Petra Kok; Hans Crezee; Udo S Gaipl; Stephan Bodis
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.